Rivastigmine tartrate and Heart attack - a phase IV clinical study of FDA data

Summary:

Heart attack is reported as a side effect among people who take Rivastigmine tartrate (rivastigmine tartrate), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Nuplazid, and have Parkinson's disease.

The phase IV clinical study analyzes which people have Heart attack when taking Rivastigmine tartrate. It is created by eHealthMe based on reports of 566 people who have side effects when taking Rivastigmine tartrate from the FDA, and is updated regularly.

What is Rivastigmine tartrate?

Rivastigmine tartrate has active ingredients of rivastigmine tartrate. eHealthMe is studying from 576 Rivastigmine tartrate users. Check the latest studies of Rivastigmine tartrate.

What is Heart attack?

Heart attack is found to be associated with 2,481 drugs and 3,296 conditions by eHealthMe. Check the latest studies of Heart attack.

On Jul, 19, 2026

566 people reported to have side effects when taking Rivastigmine tartrate.
Among them, 11 people (1.94%) have Heart attack.

Could Rivastigmine tartrate cause Heart attack?

Among these 11 people:

How long have people been on Rivastigmine tartrate when they have Heart attack? *

What is the gender of people who have Heart attack when taking Rivastigmine tartrate? *

female: 45.45 %
male: 54.55 %

What is the age of people who have Heart attack when taking Rivastigmine tartrate? *

What are other drugs people take besides Rivastigmine tartrate? *

Carbidopa And Levodopa: 5 people, 45.45%
Carbidopa, Levodopa And Entacapone: 5 people, 45.45%
Nuplazid: 5 people, 45.45%
Aspirin: 4 people, 36.36%
Myrbetriq: 3 people, 27.27%
Simvastatin: 3 people, 27.27%
Donepezil Hydrochloride: 2 people, 18.18%
Digoxin: 2 people, 18.18%
Coumadin: 2 people, 18.18%
Clopidogrel: 2 people, 18.18%

What are other side effects people have besides Heart attack? *

Hallucinations (sensations that appear real but are created by your mind): 7 people, 63.64%
Malaise (a feeling of general discomfort or uneasiness): 6 people, 54.55%
Fall: 6 people, 54.55%
Confusional State: 6 people, 54.55%
Dehydration (dryness resulting from the removal of water): 5 people, 45.45%
Delusion (a false belief or opinion): 5 people, 45.45%
Drug Ineffective: 5 people, 45.45%
Freezing Phenomenon: 5 people, 45.45%
Urinary Tract Infection: 4 people, 36.36%
Memory Loss: 4 people, 36.36%

What are the existing conditions these people have? *

Parkinson's Disease: 6 people, 54.55%
Hallucinations (sensations that appear real but are created by your mind): 5 people, 45.45%
Delusion (a false belief or opinion): 5 people, 45.45%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 2 people, 18.18%
High Blood Cholesterol: 2 people, 18.18%
Dementia (madness): 2 people, 18.18%
Gait Disturbance: 1 person, 9.09%
Diabetes: 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Rivastigmine tartrate and have Heart attack?

- Check whether Heart attack is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Rivastigmine tartrate:

Rivastigmine tartrate (576 reports)

Heart attack treatments and more:

Heart attack (266,145 reports)

Browse all side effects of Rivastigmine tartrate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Heart attack:

Heart attack (2,481 drugs)

Browse all the conditions that are associated with Heart attack:

Heart attack (3,296 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on rivastigmine tartrate (the active ingredients of Rivastigmine tartrate) and Rivastigmine tartrate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.